Keeley-Teton Advisors’s Nu Skin NUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-93,259
Closed -$3.1M 353
2023
Q2
$3.1M Sell
93,259
-4,486
-5% -$165K 0.4% 83
2023
Q1
$3.84M Sell
97,745
-3,158
-3% -$131K 0.47% 71
2022
Q4
$4.25M Sell
100,903
-5,402
-5% -$208K 0.53% 66
2022
Q3
$3.55M Sell
106,305
-3,160
-3% -$132K 0.49% 79
2022
Q2
$4.74M Sell
109,465
-12,958
-11% -$595K 0.6% 47
2022
Q1
$5.86M Sell
122,423
-3,147
-3% -$156K 0.61% 40
2021
Q4
$6.37M Sell
125,570
-1,452
-1% -$64.5K 0.68% 43
2021
Q3
$5.14M Buy
127,022
+49,908
+65% +$2.53M 0.56% 60
2021
Q2
$4.37M Buy
+77,114
New +$4.39M 0.46% 82

Other funds holding NUS

Keeley-Teton Advisors's NUS Position: Q3 2023 in Review

Keeley-Teton Advisors sold out of Nu Skin (NUS) in Q3 2023, closing a stake of 93,259 shares — an estimated $3.1M sold.

Keeley-Teton Advisors first reported a position in NUS in Q2 2021 and held it in 9 quarters. The position peaked at $6.37M in Q4 2021. 212 funds tracked by Wall St. Rank hold NUS as of Q3 2023.

  • Keeley-Teton Advisors reported no remaining Nu Skin position as of Q3 2023 after selling out during the quarter.
  • Keeley-Teton Advisors sold 93,259 Nu Skin shares in Q3 2023, an estimated $3.1M.
  • Keeley-Teton Advisors first reported a position in Nu Skin in Q2 2021 and held it in 9 quarters.
  • Keeley-Teton Advisors's Nu Skin position peaked at $6.37M in Q4 2021.
  • 212 funds tracked by Wall St. Rank held Nu Skin as of Q3 2023.

Based on Keeley-Teton Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.